GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » Market Cap

PharmaSGP Holding SE (XTER:PSG) Market Cap : €280.6 Mil (As of Apr. 06, 2025)


View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PharmaSGP Holding SE's share price for the quarter that ended in Sep. 2024 was €20.6. PharmaSGP Holding SE's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 12.0 Mil. Therefore, PharmaSGP Holding SE's market cap for the quarter that ended in Sep. 2024 was €247.0 Mil.

PharmaSGP Holding SE's quarterly market cap increased from Mar. 2024 (€262.6 Mil) to Jun. 2024 (€278.2 Mil) but then declined from Jun. 2024 (€278.2 Mil) to Sep. 2024 (€247.0 Mil).

PharmaSGP Holding SE's annual market cap increased from Dec. 2021 (€296.4 Mil) to Dec. 2022 (€319.2 Mil) but then declined from Dec. 2022 (€319.2 Mil) to Dec. 2023 (€269.8 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PharmaSGP Holding SE's Enterprise Value for Today is €243.4 Mil.


PharmaSGP Holding SE Market Cap Historical Data

The historical data trend for PharmaSGP Holding SE's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE Market Cap Chart

PharmaSGP Holding SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- 312.00 296.40 319.20 269.78

PharmaSGP Holding SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 287.76 269.78 262.58 278.17 246.99

Competitive Comparison of PharmaSGP Holding SE's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaSGP Holding SE's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaSGP Holding SE's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaSGP Holding SE's Market Cap distribution charts can be found below:

* The bar in red indicates where PharmaSGP Holding SE's Market Cap falls into.


;
;

PharmaSGP Holding SE Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

PharmaSGP Holding SE's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€22.5*11.990
=€269.8

PharmaSGP Holding SE's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€20.6*11.990
=€247.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaSGP Holding SE  (XTER:PSG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


PharmaSGP Holding SE Market Cap Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaSGP Holding SE Business Description

Traded in Other Exchanges
Address
Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166
PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.
Executives
Dr. Clemens Fischer Supervisory Board
Madlena Hohlefelder Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines